Keya Medical

Join us this Thursday, March 20 | 12 PM – 1 PM EST for a FREE sponsored webinar on AI-Derived Decision-Making and Assessment in Coronary Artery Disease (CAD).

Keya Medical SCCT Sponsored Webinar | LinkedIn **AI-derived decision-making and assessment in CAD** Join us for a FREE online webinar featuring Armin Zadeh, MD, MSCCT; Michael Blaha, MD, MPH; Dinesh Kalra, MD, FSCCT and Irfan Shafique, MD discussing DeepVessel FFRCT, AI plaque analysis, and biomarkers in risk stratification, diagnosis, predictin...

Learn about the latest in Keya Medical’s FFR CT analysis in our new blog, “DEEPVESSEL FFR CT-Recent Peer-Reviewed Publications.” Discover how the deep learning-based DEEPVESSEL FFR is used in recent studies and how you can implement this accurate and economical solution into your workflow. Read more at https://www.keyamedical.com/deepvessel-ffr-ct-publications.

DEEPVESSEL FFR CT-Recent Peer-Reviewed Publications - KeyaMedical Following is a sampling of recent peer-reviewed publications and more studies with DEEPVESSEL FFR CT are in progress.

Keya Medical is excited to announce that DEEPVESSEL FFR, a deep-learning-based FFR CT analysis, is now available in the USA.

Keya Medical's FFR CT analysis DEEPVESSEL® is now available in the USA. - KeyaMedical Deep-learning based, non-invasive, accurate, and accessible CT-FFR test helps physicians diagnose and treat heart decease.

What is new in the 2021 AHA/ACC Guidelines for the Evaluation and Diagnosis of Chest Pain? Learn more about shared decision-making, structured assessment, and the increased interest in Coronary CTA as a first-line test and CT-FFR as an add-on test.

2021 ACC AHA Guideline Promotes Shared Decision-Making - KeyaMedical CCTA as a First Line Test and FFR-CT as an Add-on Test, SCCT Webcasts, Structured Assessment, CCTA and FFR-CT Utilization Growth Seen